Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Pulmonology & Critical Care

What are the common patterns in vaping-associated acute lung injury cases?

Vaping-associated acute lung injury is often linked to products containing cannabinoids and frequently presents with patterns like diffuse alveolar damage or organizing pneumonia.

Pulmonology & Critical Care

Can biomimetic nanosystems be used to treat sepsis-induced acute lung injury?

Biomimetic nanosystems inspired by extracellular vesicles are being studied as a promising way to balance immune responses and treat sepsis-induced acute lung injury.

Pulmonology & Critical Care

Are extracellular vesicles a potential treatment for sepsis-related acute lung injury?

Extracellular vesicles show potential as both a contributor and a therapeutic target in sepsis-related acute lung injury, but clinical use is still experimental.

Pulmonology & Critical Care

Does miRNA regulation of neutrophils help treat acute lung injury?

Research suggests that microRNAs (miRNAs) can regulate neutrophil behavior and may offer a promising way to treat acute lung injury, though most evidence currently comes from…

Pulmonology & Critical Care

Is recombinant human plasma gelsolin safe to use for acute lung injury?

Recombinant human plasma gelsolin (rhu-pGSN) was found to be safe and well-tolerated in a Phase 1 trial involving healthy volunteers.

Gastroenterology

Are gut metabolites linked to obesity and conditions like fatty liver?

Yes, gut metabolites like short-chain fatty acids and bile acids are linked to obesity and fatty liver, with dysbiosis driving inflammation and metabolic dysfunction.

Gastroenterology

Can the compound EGCG help treat digestive system diseases and fatty liver?

EGCG shows promise for treating fatty liver and other digestive diseases in animal and lab studies, but human trials are still needed to confirm its effectiveness.

Gastroenterology

Do quercetin and apigenin show promise for treating non-alcoholic fatty liver disease?

Yes, quercetin and apigenin show promise for NAFLD by reducing liver fat and inflammation, but most evidence comes from lab and animal studies; human trials are limited.

OB/GYN & Women's Health

Can creatine monohydrate supplements help postmenopausal women gain lean muscle mass?

Yes, creatine monohydrate supplements can help postmenopausal women gain lean muscle mass, especially when combined with resistance training.

Oncology

How does innate immune recognition affect the progression of Cervical Cancer and HPV?

HPV evades innate immune detection by suppressing PRR signaling and NLRP3 inflammasome, enabling persistent infection and cervical cancer progression.

Oncology

Does conversion surgery improve survival rates for patients with cT4 Esophageal Cancer?

Yes, conversion surgery after induction therapy significantly improves survival for cT4 esophageal cancer, with 5-year survival of 26.5% vs 11.6% for definitive therapy alone.

Gastroenterology

Does robot-assisted esophagectomy reduce blood loss and hospital stays for Esophageal Cancer?

Yes, robot-assisted esophagectomy reduces blood loss and hospital stays compared to conventional minimally invasive approaches for esophageal cancer, based on systematic reviews.

Oncology

Do older age or other health issues increase complications after surgery for Esophageal Cancer?

While older age and other health issues are often associated with higher risks in open surgeries, research suggests they may not increase the risk of severe complications for…

Oncology

Does EGCG have therapeutic effects on digestive system diseases like Esophageal Cancer?

EGCG shows promise against esophageal cancer in lab and animal studies, and a human trial found it reduced radiation-induced esophagitis, but more clinical research is needed.

Oncology

Can relacorilant and nab-paclitaxel help patients with platinum-resistant Ovarian Cancer?

Yes, relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer, based on phase 2 and phase 3 trial results.

Oncology

Do PARP inhibitors improve survival for patients with BRCA-mutated Ovarian Cancer?

Yes, PARP inhibitors significantly improve progression-free survival for patients with BRCA-mutated ovarian cancer, with some studies also showing overall survival benefits.

Oncology

Is [68Ga]Ga-FAPI PET imaging accurate for diagnosing Ovarian Cancer?

Yes, [68Ga]Ga-FAPI PET imaging is highly accurate for diagnosing ovarian cancer, especially for detecting peritoneal and lymph node metastases, and may outperform standard FDG…

OB/GYN & Women's Health

Does taking birth control pills lower the risk of getting Ovarian Cancer?

Yes, taking birth control pills is associated with a lower risk of ovarian cancer, especially with longer use.

Pulmonology & Critical Care

Are there different mortality rates for various viruses causing hypoxemia?

Yes, mortality rates differ by virus. In a large US cohort, influenza had lower death odds than SARS-CoV-2, while RSV also had lower odds, but all three caused similar rates of…

Oncology

What is the focus of current clinical trials for Non-Hodgkin's Lymphoma?

Current clinical trials for non-Hodgkin's lymphoma (NHL) focus heavily on early-phase development of CAR-T cell therapies and the evaluation of bispecific antibodies.

Oncology

Does adding gemcitabine improve survival for muscle-invasive bladder cancer patients?

Yes, adding gemcitabine to cisplatin-based chemotherapy improves survival for muscle-invasive bladder cancer patients, as shown in the NIAGARA trial.

Urology

Can machine learning help predict risks before surgery for bladder cancer?

Yes, machine learning models using CT scans and clinical data can predict survival and metastasis risk before bladder cancer surgery, with some models achieving high accuracy.

Oncology

Is cisplatin better than carboplatin for surviving advanced bladder cancer?

Yes, cisplatin-based chemotherapy is associated with better overall survival than carboplatin for advanced bladder cancer, but carboplatin is used when patients cannot tolerate…

Urology

Does adding mitomycin to BCG help high-risk non-muscle-invasive bladder cancer?

No, adding mitomycin to BCG did not improve disease-free survival in high-risk NMIBC patients in a large randomized trial.

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.